Literature DB >> 34610287

Chronic methamphetamine-induced neurodegeneration: Differential vulnerability of ventral tegmental area and substantia nigra pars compacta dopamine neurons.

Yijuan Du1, You Bin Lee1, Steven M Graves2.   

Abstract

Methamphetamine (meth) increases monoamine oxidase (MAO)-dependent mitochondrial stress in substantia nigra pars compacta (SNc) axons; chronic administration produces SNc degeneration that is prevented by MAO inhibition suggesting that MAO-dependent axonal mitochondrial stress is a causal factor. To test whether meth similarly increases mitochondrial stress in ventral tegmental area (VTA) axons, we used a genetically encoded redox biosensor to assess mitochondrial stress ex vivo. Meth increased MAO-dependent mitochondrial stress in both SNc and VTA axons. However, despite having the same meth-induced stress as SNc neurons, VTA neurons were resistant to chronic meth-induced degeneration indicating that meth-induced MAO-dependent mitochondrial stress in axons was necessary but not sufficient for degeneration. To determine whether L-type Ca2+ channel-dependent stress differentiates SNc and VTA axons, as reported in the soma, the L-type Ca2+ channel activator Bay K8644 was used. Opening L-type Ca2+ channels increased axonal mitochondrial stress in SNc but not VTA axons. To first determine whether mitochondrial stress was necessary for SNc degeneration, mice were treated with the mitochondrial antioxidant mitoTEMPO. Chronic meth-induced SNc degeneration was prevented by mitoTEMPO thereby confirming the necessity of mitochondrial stress. Similar to results with the antioxidant, both MAO inhibition and L-type Ca2+ channel inhibition also prevented SNc degeneration. Taken together the presented data demonstrate that both MAO- and L-type Ca2+ channel-dependent mitochondrial stress is necessary for chronic meth-induced degeneration.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  L-type Ca(2+) channel; Methamphetamine; Mitochondrial stress; Monoamine oxidase; Neurodegeneration; Substantia nigra pars compacta; Ventral tegmental area

Mesh:

Substances:

Year:  2021        PMID: 34610287      PMCID: PMC8556701          DOI: 10.1016/j.neuropharm.2021.108817

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  98 in total

Review 1.  Somatodendritic dopamine release: recent mechanistic insights.

Authors:  Margaret E Rice; Jyoti C Patel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

2.  iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease.

Authors:  Chris M Woodard; Brian A Campos; Sheng-Han Kuo; Melissa J Nirenberg; Michael W Nestor; Matthew Zimmer; Eugene V Mosharov; David Sulzer; Hongyan Zhou; Daniel Paull; Lorraine Clark; Eric E Schadt; Sergio Pablo Sardi; Lee Rubin; Kevin Eggan; Mathew Brock; Scott Lipnick; Mahendra Rao; Stephen Chang; Aiqun Li; Scott A Noggle
Journal:  Cell Rep       Date:  2014-11-06       Impact factor: 9.423

3.  Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling.

Authors:  Jean-Francois Poulin; Jian Zou; Janelle Drouin-Ouellet; Kwang-Youn A Kim; Francesca Cicchetti; Rajeshwar B Awatramani
Journal:  Cell Rep       Date:  2014-10-30       Impact factor: 9.423

4.  Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; M Leonido-Yee; D Franceschi; M J Sedler; S J Gatley; R Hitzemann; Y S Ding; J Logan; C Wong; E N Miller
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

Review 5.  The catecholaldehyde hypothesis: where MAO fits in.

Authors:  David S Goldstein
Journal:  J Neural Transm (Vienna)       Date:  2019-12-05       Impact factor: 3.575

6.  Calbindin D-28k Protein and mRNA Localization in the Rat Brain.

Authors:  J. M. Séquier; W. Hunziker; C. Andressen; M. R. Celio
Journal:  Eur J Neurosci       Date:  1990       Impact factor: 3.386

Review 7.  Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms.

Authors:  Rosario Moratalla; Amit Khairnar; Nicola Simola; Noelia Granado; Jose Ruben García-Montes; Pier Francesca Porceddu; Yousef Tizabi; Giulia Costa; Micaela Morelli
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

8.  Why is parkinsonism not a feature of human methamphetamine users?

Authors:  Anna Moszczynska; Paul Fitzmaurice; Lee Ang; Kathryn S Kalasinsky; Gregory A Schmunk; Frank J Peretti; Sally S Aiken; Dennis J Wickham; Stephen J Kish
Journal:  Brain       Date:  2003-11-25       Impact factor: 13.501

9.  Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain.

Authors:  Zachary Freyberg; Mark S Sonders; Jenny I Aguilar; Takato Hiranita; Caline S Karam; Jorge Flores; Andrea B Pizzo; Yuchao Zhang; Zachary J Farino; Audrey Chen; Ciara A Martin; Theresa A Kopajtic; Hao Fei; Gang Hu; Yi-Ying Lin; Eugene V Mosharov; Brian D McCabe; Robin Freyberg; Kandatege Wimalasena; Ling-Wei Hsin; Dalibor Sames; David E Krantz; Jonathan L Katz; David Sulzer; Jonathan A Javitch
Journal:  Nat Commun       Date:  2016-02-16       Impact factor: 14.919

10.  Methamphetamine Overdose Deaths in the US by Sex and Race and Ethnicity.

Authors:  Beth Han; Jessica Cotto; Kathleen Etz; Emily B Einstein; Wilson M Compton; Nora D Volkow
Journal:  JAMA Psychiatry       Date:  2021-05-01       Impact factor: 21.596

View more
  2 in total

1.  Differential vulnerability of locus coeruleus and dorsal raphe neurons to chronic methamphetamine-induced degeneration.

Authors:  Yijuan Du; Sanghoon Choi; Alexander Pilski; Steven M Graves
Journal:  Front Cell Neurosci       Date:  2022-07-22       Impact factor: 6.147

2.  Effects of moderate-intensity exercise on social health and physical and mental health of methamphetamine-dependent individuals: A randomized controlled trial.

Authors:  Jisheng Xu; Zhicheng Zhu; Xin Liang; Qiuyue Huang; TianZhen Zheng; Xue Li
Journal:  Front Psychiatry       Date:  2022-09-23       Impact factor: 5.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.